In this study, we revealed the inhibitory effect of (D-Ala2)GIP on TNF-α-induced osteoclast formation and bone resorption in vivo, highlighting the potential of targeting GIP signaling as a therapeutic strategy for TNF-α-associated inflammatory bone diseases. The gene discussed is TNF; the disease is bone inflammation disease.